GVK Biosciences

Dr. John Ellingboe has been appointed senior vice president of Discovery Chemistry for GVK Biosciences. Dr. Ellingboe will report to Mr. Manni Kantipudi, president of GVK Biosciences.

Prior to joining the company, Dr. Ellingboe worked with Wyeth Research and Pfizer for 25 years in senior scientific positions and has extensive medicinal chemistry and drug discovery experience. During his time at Wyeth, he established a core parallel synthesis group, a lead identification group, and an integrated medicinal chemistry group working in all phases of drug discovery. His responsibilities included the identification of leads and development candidates across multiple therapeutic areas and leading a department across several research sites. While at Wyeth, he also initiated and managed a large chemistry partnership with GVK BIO.

“I am pleased to welcome John on board. As senior vice president, Discovery Chemistry, John will lead the Medicinal Chemistry efforts of various Collaborative Research programs and will play a key role in guiding the company’s future Collaborative Research efforts,” said Sanjay Reddy, managing director, GVK Biosciences.